UPEXI, INC. Files 8-K: Regulation FD, Other Events

Ticker: UPXI · Form: 8-K · Filed: Jun 20, 2025 · CIK: 1775194

Upexi, Inc. 8-K Filing Summary
FieldDetail
CompanyUpexi, Inc. (UPXI)
Form Type8-K
Filed DateJun 20, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: regulation-fd, other-events, filing

TL;DR

UPEXI, INC. dropped an 8-K on 6/17/25 covering Reg FD and other events. Check it out.

AI Summary

On June 17, 2025, UPEXI, INC. filed an 8-K report detailing a Regulation FD Disclosure and Other Events. The filing also includes financial statements and exhibits. The company, formerly known as GROVE, INC., is incorporated in Nevada and operates in the Medicinal Chemicals & Botanical Products sector.

Why It Matters

This 8-K filing provides timely updates on UPEXI, INC.'s corporate activities, including regulatory disclosures and other significant events, which are crucial for investors to monitor.

Risk Assessment

Risk Level: low — The filing is a standard 8-K reporting routine events and disclosures, not indicating immediate financial distress or significant operational changes.

Key Numbers

  • 001-40535 — SEC File Number (Identifies the company's filing with the SEC.)
  • 83-3378978 — EIN (Employer Identification Number for tax purposes.)

Key Players & Entities

  • UPEXI, INC. (company) — Registrant
  • GROVE, INC. (company) — Former Company Name
  • June 17, 2025 (date) — Date of earliest event reported
  • Nevada (jurisdiction) — State of Incorporation
  • 3030 N. Rocky Point Drive , Suite 420 Tampa , FL 33607 (address) — Principal Executive Offices

FAQ

What specific events are covered under 'Other Events' in this 8-K filing?

The filing indicates 'Other Events' as an item, but the specific details of these events are not provided in the excerpt.

What is the significance of the 'Regulation FD Disclosure' mentioned?

A Regulation FD Disclosure ensures that material non-public information is broadly disseminated to the public, preventing selective disclosure.

When did UPEXI, INC. change its name from GROVE, INC.?

The filing states the date of name change was 20190429.

What industry does UPEXI, INC. operate in?

UPEXI, INC. operates in the MEDICINAL CHEMICALS & BOTANICAL PRODUCTS sector, with SIC code 2833.

Where are UPEXI, INC.'s principal executive offices located?

The principal executive offices are located at 3030 N. Rocky Point Drive, Suite 420, Tampa, FL 33607.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on June 20, 2025 regarding UPEXI, INC. (UPXI).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.